Anzeige
Mehr »
Mittwoch, 13.08.2025 - Börsentäglich über 12.000 News
Diese Aktie liegt in der Turbo-Zone - und könnte der Gold-Gewinner 2025/26 werden!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
05.08.Vertex is smarting from a pain portfolio setback
05.08.Noom expands its GLP-1 range with 'microdose' package
05.08.Gates Foundation puts $2.5bn into 'ignored' women's health
05.08.NICE calls for better care after weight-loss therapy ends
05.08.Gedeon Richter brings HRT option back to the UK market
04.08.Top medical groups barred from CDC vaccine workgroups
04.08.UK starts 'world-first' gonorrhoea vaccination push
04.08.EVERSANA unveils industry's 'first AI marketing agency'
04.08.After phase 3 hit, Spine seeks path forward for pain drug
04.08.Sanofi grabs Chinese rights to Arrowhead rare disease drug
01.08.NHS broadens access to haemophilia A drug Hemlibra
01.08.ChatGPT can cut review times for clinical trial eligibility
01.08.Tech giants back unified health data-sharing platform in US
31.07.Trump gives pharma ultimatum on most favoured nation pricing
31.07.Moderna cuts staff amid operating 'uncertainty'
31.07.Lilly trumpets heart health data with Mounjaro
31.07.Google wearable AI can 'learn the language of our bodies'
31.07.Is AbbVie planning an epic Gilgamesh takeover?
31.07.Tidmarsh to stand in for Prasad's role at CBER
30.07.NICE CEO to step down by year-end
30.07.AbbVie files to move Venclexta combo into the CLL front line
30.07.AI picks up interval breast cancers missed by scans
30.07.GSK suffers a setback with its TIM-3 programme
30.07.White House retreats from block on NIH research funding
30.07.Vinay Prasad abruptly departs from the FDA